Evidence map›Paper›PMID 36713452›Full record

ArticleFrontiers in immunology2022

Temporal trends of COVID-19 antibodies in vaccinated healthcare workers undergoing repeated serological sampling: An individual-level analysis within 13 months in the ORCHESTRA cohort.

Giulia Collatuzzo, Giuseppe De Palma, Francesco S Violante, Stefano Porru, Francesca Larese Filon, Eleonora Fabianova, Concepción Violán, Luigi Vimercati, Mihaela Leustean, Marta Maria Rodriguez-Suarez and 14 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 11 institutions in 4 countries.

Giulia CollatuzzoDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Giuseppe De PalmaDepartment of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
Francesco S ViolanteDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Stefano PorruSection of Occupational Medicine, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Francesca Larese FilonUnit of Occupational Medicine, University of Trieste, Trieste, Italy.
Eleonora FabianovaOccupational Health Department, Regional Authority of Public Health, Banská Bystrica, Slovakia.
Concepción ViolánUnitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Mataró, Spain.
Luigi VimercatiInterdisciplinary Department of Medicine, University of Bari, Bari, Italy.
Mihaela LeusteanNational Institute of Public Health, Bucharest, Romania.
Marta Maria Rodriguez-SuarezInstituto de Investigación Sanitaria del Principado de Asturias (ISPA) and Universitario Central de Asturias (HUCA), University of Oviedo, Oviedo, Spain.
Emanuele SansoneOccupational Medicine Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Emma SalaUnit of Occupational Health, Hygiene, Toxicology and Prevention, ASST Ospedali Civili di Brescia, Brescia, Italy.
Carlotta ZunarelliDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Vittorio LodiOccupational Medicine Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Maria Grazia Lourdes MonacoOccupational Medicine Unit, University Hospital of Verona, Verona, Italy.
Gianluca SpiteriOccupational Medicine Unit, University Hospital of Verona, Verona, Italy.
Corrado NegroUnit of Occupational Medicine, University of Trieste, Trieste, Italy.
Jana BeresovaOccupational Health Department, Regional Authority of Public Health, Banská Bystrica, Slovakia.
LucÌa A Carrasco-RibellesUnitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Mataró, Spain.
Silvio TafuriInterdisciplinary Department of Medicine, University of Bari, Bari, Italy.
Shuffield S AsafoDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Giorgia DitanoDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Mahsa AbediniDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Paolo BoffettaDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
University of Bologna · ITUniversity of Verona · ITPublic Health Authority of the Slovak Republic · SKUniversity of Bari Aldo Moro · ITUniversity of Brescia · ITUniversity of Trieste · ITAzienda USL di Bologna · ITInstitut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ESInstituto de Investigación Sanitaria del Principado de Asturias · ESInstitut Universitari d'Investigació en Atenció Primària Jordi Gol · ESStony Brook University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Short summary: We investigated changes in serologic measurements after COVID-19 vaccination in 19,422 subjects. An individual-level analysis was performed on standardized measurements. Age, infection, vaccine doses, time between doses and serologies, and vaccine type were associated with changes in serologic levels within 13 months. Background: Persistence of vaccine immunization is key for COVID-19 prevention. Methods: We investigated the difference between two serologic measurements of anti-COVID-19 S1 antibodies in an individual-level analysis on 19,422 vaccinated healthcare workers (HCW) from Italy, Spain, Romania, and Slovakia, tested within 13 months from first dose. Differences in serologic levels were divided by the standard error of the cohort-specific distribution, obtaining standardized measurements. We fitted multivariate linear regression models to identify predictors of difference between two measurements. Results: We observed a progressively decreasing difference in serologic levels from <30 days to 210-240 days. Age was associated with an increased difference in serologic levels. There was a greater difference between the two serologic measurements in infected HCW than in HCW who had never been infected; before the first measurement, infected HCW had a relative risk (RR) of 0.81 for one standard deviation in the difference [95% confidence interval (CI) 0.78-0.85]. The RRs for a 30-day increase in time between first dose and first serology, and between the two serologies, were 1.08 (95% CI 1.07-1.10) and 1.04 (95% CI 1.03-1.05), respectively. The first measurement was a strong predictor of subsequent antibody decrease (RR 1.60; 95% CI 1.56-1.64). Compared with Comirnaty, Spikevax (RR 0.83, 95% CI 0.75-0.92) and mixed vaccines (RR 0.61, 95% CI 0.51-0.74) were smaller decrease in serological level (RR 0.46; 95% CI 0.40-0.54). Conclusions: Age, COVID-19 infection, number of doses, time between first dose and first serology, time between serologies, and type of vaccine were associated with differences between the two serologic measurements within a 13-month period.

Indexed as

COVID-19COVID-19 VaccinesAntibodiesHealth PersonnelHumansInfantItalyAntibodiesCOVID-19 VaccinesantibodiesCOVID-19 vaccinationhealth care workersserial serologytemporal trends

Identifiers

PMID36713452
PMCPMC9875291
OpenAlexW4315574346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.